Organization: Health Canada
Year: 2025
Month: February
Request Number: A-2024-001376
Request Summary: Adverse Drug Reactions (ADRs) for Entyvio. Report numbers: E2B_07520861, E2B_07547134. ADRs for Vedolizumab. Report numbers: E2B_07563950, E2B_07544365. ADRs for Ondansetron. Report numbers: E2B_07522293, E2B_07523070, E2B_07558327, E2B_07546410, E2B_07560106, E2B_07554936.
Disposition: Disclosed in part
Number of pages: 2773